Precision BioLogic Inc. presented MNBA data at the World Federation of Hemophilia (WFH) 2018 World Congress in Glasgow, Scotland, May 20–24. Recognizing the need to improve factor VIII (FVIII ) inhibitor testing for people with hemophilia A, the company studied the agreement between a chromogenic modified Nijmegen-Bethesda assay (MNBA) and a qualitative ELISA test in the detection of FVIII inhibitors in plasma samples.
Posts - Events
Jun 7, 2018 1:04pm
Apr 23, 2018 10:07am
Good day, and welcome to Medical Laboratory Professionals week, April 22–28, 2018. Congratulations and thanks to medical laboratory technicians, scientists, managers, and directors worldwide whose products support at
Apr 21, 2018 6:14pm
Please see the attached Precision BioLogic post card announcing our special case study series developed for Medical Laboratory Professionals' Week, April 22–28, 2018: /sites/default/files/lab_week_cards_2018_0.pdf
Apr 17, 2018 7:29am